Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease.
Journal Article (Journal Article)
Degeneration of the nigrostriatal dopaminergic pathway, the hallmark of Parkinson's disease, can be recapitulated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. Herein, we demonstrate that adoptive transfer of copolymer-1 immune cells to MPTP recipient mice leads to T cell accumulation within the substantia nigra pars compacta, suppression of microglial activation, and increased local expression of astrocyte-associated glial cell line-derived neurotrophic factor. This immunization strategy resulted in significant protection of nigrostriatal neurons against MPTP-induced neurodegeneration that was abrogated by depletion of donor T cells. Such vaccine treatment strategies may provide benefit for Parkinson's disease.
Full Text
Duke Authors
Cited Authors
- Benner, EJ; Mosley, RL; Destache, CJ; Lewis, TB; Jackson-Lewis, V; Gorantla, S; Nemachek, C; Green, SR; Przedborski, S; Gendelman, HE
Published Date
- June 22, 2004
Published In
Volume / Issue
- 101 / 25
Start / End Page
- 9435 - 9440
PubMed ID
- 15197276
Pubmed Central ID
- PMC438994
International Standard Serial Number (ISSN)
- 0027-8424
Digital Object Identifier (DOI)
- 10.1073/pnas.0400569101
Language
- eng
Conference Location
- United States